Skip to content

Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices

Testing Spread and Implementation of Novel MRSA-Reducing Practices

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01255943
Enrollment
175
Registered
2010-12-08
Start date
2010-07-31
Completion date
2012-04-30
Last updated
2021-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Stream Infections, MRSA Infections

Keywords

MRSA, bloodstream infections, hemodialysis

Brief summary

The purpose of this study is to implement strategies for improved efficiency and waste reduction (Toyota Lean) and positive deviance, a social behavioral change process, utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA infection in outpatient dialysis care. In two outpatient dialysis units, dialysis unit healthcare staff will be educated in Toyota lean techniques and conduct periodic discovery and action dialogues to identify and implement care process changes to reduce infection. Outcomes to be monitored will include incidence of bloodstream infections and MRSA infections of all types. Data will be assessed at quarterly intervals using interrupted time series analysis.

Interventions

BEHAVIORALhealthcare staff processes for infection prevention

Toyota lean and positive deviance discovery and action dialogues to facilitate process improvement

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Indiana University School of Medicine
CollaboratorOTHER
MaineHealth
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

all hemodialysis patients at two outpatient dialysis units

Exclusion criteria

peritoneal dialysis patients

Design outcomes

Primary

MeasureTime frame
Incidence of bloodstream infections14 months

Secondary

MeasureTime frame
Incidence of MRSA infections14 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026